• Trending
  • Latest
    Sign in Sign up
    • Log In
    • Register
    • Home
    • Discover
    • Experts
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Home
    • Discover
    • Experts
    • Learning Lab
    • Mashup Score: 0
      Sun Shield: Protecting Beyond Ultraviolet Light - 5 hour(s) ago

      Susan Taylor, MD, FAAD, discusses the impact of the solar spectrum on skin health, focusing specifically on the impact of visible light and infrared radiation. She discusses the benefits and limitations of traditional sunscreen ingredients and addresses ways to specifically protect from visible light and infrared radiation. Additionally, she discusses the impact of free radical formation on skin health and how adding antioxidants to sunscreen might optimize skin protection. She also shares her perspective based on her clinical experience on how she talks to her patients about sun protection and how she chooses the right sunscreen for patients in her practice.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        🎥 Sunscreen is just the start. Teach patients how antioxidants plus SPF can help combat free radical damage for healthier skin: https://t.co/U9ZsqI5taL https://t.co/W2u15caR8N

    • Mashup Score: 0
      Late Breaking Data: Long-Term Safety and Efficacy of Nemolizumab for AD - 7 hour(s) ago

      Galderma unveils promising long-term data on nemolizumab for atopic dermatitis, showcasing significant skin improvement and quality of life enhancements.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        🚨 At #RAD2025, Galderma shared 104-week data showing #nemolizumab delivers lasting skin clearance, itch relief, and improved quality of life in moderate-to-severe #AD, whether patients were new or experienced with the drug. https://t.co/fL03j5giV7 #AtopicDermatitis #DermTwitter

    • Mashup Score: 0
      Integrating Ruxolitinib, Excimer Laser, and Emerging Therapies for Vitiligo - 9 hour(s) ago

      At a recent Dermatology Times Case-Based Roundtable event, Michael Gold, MD, explored innovative vitiligo treatment strategies through complex cases and emerging therapies.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        💡 At an exclusive Dermatology Times Case-Based Roundtable event, Michael Gold, MD reviewed complex #vitiligo cases, highlighting #ruxolitinib, excimer laser, and new therapies. https://t.co/ZaJ1C3ohED

    • Mashup Score: 1
      SDNP President Amanda Caldwell, MSN, APRN-C, on Empowering NPs Through Enhanced Support and Education - 11 hour(s) ago

      Amanda Caldwell, MSN, APRN-C, is fostering community and collaboration for NPs and PAs as the new president of the SDNP.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        💡 Amanda Caldwell, MSN, APRN-C, new #SDNP president, is expanding support for dermatology NPs snd PAs with more research, education tools, and community outreach. https://t.co/FtobUX94Zr #DermTwitter

    • Mashup Score: 0
      Empowered Aging and the Rise of Confidence-Based Care with Shannon Humphrey, MD, and Merz Aesthetics - 13 hour(s) ago

      Shannon Humphrey, MD, leads a shift in aesthetic dermatology towards patient empowerment and self-care, supported by Merz Aesthetics’ Pillars of Confidence study.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        📈 Shannon Humphrey, MD and Merz Aesthetics highlight new data showing aesthetic patients seek treatments for confidence and wellness over vanity, ushering in an era of personalized, patient-first aging. https://t.co/KkfcqMa52k #DermTwitter

    • Mashup Score: 0
      Journal Digest: June 11, 2025 - 15 hour(s) ago

      This review of the latest dermatologic studies includes insights into skin improvement with injectable hyaluronic acid, burden of chronic spontaneous urticaria, and more.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        📚 In this week's edition of the Journal Digest, we review the latest dermatologic insights including skin improvement with injectable hyaluronic acid, burden of chronic spontaneous urticaria, and more. https://t.co/xanu343qmk #JournalDigest #DermTwitter

    • Mashup Score: 0
      Strategies for Managing Alopecia Areata - 1 day(s) ago

      Susan Taylor, MD, FAAD, discusses a review of the management of alopecia areata through patient cases. She examines real-world scenarios and addresses some of the challenges that are commonly encountered when treating severe alopecia areata. Throughout the discussion, she shares some of her own practice-based insights and strategies for optimizing patient care in alopecia areata.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        🎥 How can clinicians support patients through the physical and emotional challenges of alopecia areata? This Case-Based Peer Perspective series breaks it down: https://t.co/FgiQ01Vt0z https://t.co/NHNJ68TrJ0

    • Mashup Score: 0
      Late-Breaking Data: Flexible Dosing of Abrocitinib for AD Shows Real-World Promise - 1 day(s) ago

      The JADE REAL study reported that flexible dosing of abrocitinib exhibited promise in patients with moderate to severe AD.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        👥🎸 Late-breaking results of the JADE REAL study, presented at #RAD2025, show flexible dosing of #abrocitinib is safe, effective, and mirrors real-world use for moderate to severe atopic dermatitis. https://t.co/zOV6kLu8Mj #AtopicDermatitis #DermTwitter

    • Mashup Score: 0
      Beyond the Clinic: How the Mobile Destination Healthy Skin Initiative Saved Peter Graylin’s Life - 1 day(s) ago

      Peter Graylin shares his transformative skin cancer journey, emphasizing the importance of early detection, sun safety, and accessible dermatology programs.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        💡 #Melanoma survivor Peter Graylin shares how a chance visit to EltaMD and The Skin Cancer Foundation’s Destination Healthy Skin mobile unit led to early cancer detection, changing his life and sun habits. https://t.co/uxJmc30pFI #SkinCancer #DermTwitter

    • Mashup Score: 0
      From Patient to President: Amanda Caldwell, MSN, APRN-C, And Her Journey with SDNP - 1 day(s) ago

      Amanda Caldwell, MSN, APRN-C, is promoting accessibility, education, and relatability as the newly inducted president of the Society for Dermatology Nurse Practitioners.

      Source: www.dermatologytimes.com
      Categories: General Medicine News, Dermatology
      Tweet Tweets with this article
      • Profile photo of 	DermTimesNow
        DermTimesNow

        💡 Amanda Caldwell, MSN, APRN-C, is the new president of the Society for Dermatology Nurse Practitioners (#SDNP), aiming to expand education, support, and job access for dermatology NPs and PAs. https://t.co/2Q4xnifh0N #DermTwitter

    Load More

    Dermatology Times

    @DermTimesNow

    Dermatology Times: The latest news and trends in dermatologic procedures, therapy, technology, products and drugs.

    ASCO 2025

    Advertisement

    Advertisement

    MashupMD
    © 2025 - Mashup Media LLC
    • Terms of Use
    • Privacy Policy
    • Cookie Settings